95 related articles for article (PubMed ID: 3828467)
1. Interaction of human low density lipoprotein and apolipoprotein B with ternary lipid microemulsion. Physical and functional properties.
Chun PW; Brumbaugh EE; Shiremann RB
Biophys Chem; 1986 Dec; 25(3):223-41. PubMed ID: 3828467
[TBL] [Abstract][Full Text] [Related]
2. Fusion of low density lipoproteins with cholesterol ester-phospholipid microemulsions. Prevention of particle fusion by apolipoprotein A-I.
Parks JS; Martin JA; Johnson FL; Rudel LL
J Biol Chem; 1985 Mar; 260(5):3155-63. PubMed ID: 3919017
[TBL] [Abstract][Full Text] [Related]
3. Preparation of biologically active analogs of serum low density lipoprotein.
Lundberg B; Suominen L
J Lipid Res; 1984 Jun; 25(6):550-8. PubMed ID: 6747459
[TBL] [Abstract][Full Text] [Related]
4. Extraction of the apo B cluster from human low density lipoprotein with Tween 80.
Ikai A
J Biochem; 1980 Nov; 88(5):1349-57. PubMed ID: 7462184
[TBL] [Abstract][Full Text] [Related]
5. Interaction of apolipoprotein B from human serum low-density lipoprotein with egg yolk phosphatidylcholine and cholesterol.
Dhawan S; Reynolds JA
Biochemistry; 1983 Jul; 22(15):3660-4. PubMed ID: 6684478
[TBL] [Abstract][Full Text] [Related]
6. Binding of lipoprotein lipase to apolipoprotein B-containing lipoproteins.
Carrero P; Gómez-Coronado D; Olivecrona G; Lasunción MA
Biochim Biophys Acta; 1996 Jan; 1299(2):198-206. PubMed ID: 8555265
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein B-32: a new truncated mutant of human apolipoprotein B capable of forming particles in the low density lipoprotein range.
McCormick SP; Fellowes AP; Walmsley TA; George PM
Biochim Biophys Acta; 1992 Apr; 1138(4):290-6. PubMed ID: 1562615
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein B-100 conformation and particle surface charge in human LDL subspecies: implication for LDL receptor interaction.
Lund-Katz S; Laplaud PM; Phillips MC; Chapman MJ
Biochemistry; 1998 Sep; 37(37):12867-74. PubMed ID: 9737865
[TBL] [Abstract][Full Text] [Related]
10. [Small dense LDL concentration is closely associated with serum apolipoprotein B, comparisons of non-LDL cholesterol or LDL cholesterol].
Hayashi T; Hirano T; Shiobara T; Suguro T; Adachi M
Rinsho Byori; 2006 Jun; 54(6):569-75. PubMed ID: 16872005
[TBL] [Abstract][Full Text] [Related]
11. Influence of triglyceride concentration on the relationship between lipoprotein cholesterol and apolipoprotein B and A-I levels.
Leroux G; Lemieux I; Lamarche B; Cantin B; Dagenais GR; Lupien PJ; Després JP
Metabolism; 2000 Jan; 49(1):53-61. PubMed ID: 10647064
[TBL] [Abstract][Full Text] [Related]
12. Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia.
Ehnholm C; Mahley RW; Chappell DA; Weisgraber KH; Ludwig E; Witztum JL
Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5566-70. PubMed ID: 6591204
[TBL] [Abstract][Full Text] [Related]
13. Selective isolation of human plasma low-density lipoprotein particles containing apolipoproteins B and E by use of a monoclonal antibody to apolipoprotein B.
Koren E; Alaupovic P; Lee DM; Dashti N; Kloer HU; Wen G
Biochemistry; 1987 May; 26(10):2734-40. PubMed ID: 3606988
[TBL] [Abstract][Full Text] [Related]
14. Interaction of low-density lipoproteins with gangliosides.
Mikhailenko IA; Dubrovskaya SA; Korepanova OB; Timofeeva NG; Morozkin AD; Prokazova NV; Bergelson LD
Biochim Biophys Acta; 1991 Oct; 1085(3):299-305. PubMed ID: 1911863
[TBL] [Abstract][Full Text] [Related]
15. Small supplements of N-3 fatty acids change serum low density lipoprotein composition by decreasing phospholid and apolipoprotein B concentrations in young adult women.
Sanchez-Muniz FJ; Bastida S; Viejo JM; Terpstra AH
Eur J Nutr; 1999 Feb; 38(1):20-7. PubMed ID: 10338684
[TBL] [Abstract][Full Text] [Related]
16. Does the presence of the 3500 mutant apolipoprotein B-100 in low density lipoprotein particles affect their atherogenicity?
Maher VM; Gallagher JJ; Thompson GR; Myant NB
Atherosclerosis; 1995 Nov; 118(1):105-10. PubMed ID: 8579620
[TBL] [Abstract][Full Text] [Related]
17. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
[TBL] [Abstract][Full Text] [Related]
18. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein B-100 deficiency. Intestinal steatosis despite apolipoprotein B-48 synthesis.
Herbert PN; Hyams JS; Bernier DN; Berman MM; Saritelli AL; Lynch KM; Nichols AV; Forte TM
J Clin Invest; 1985 Aug; 76(2):403-12. PubMed ID: 4031057
[TBL] [Abstract][Full Text] [Related]
20. Acute changes in lipid, lipoprotein, apolipoprotein, and low-density lipoprotein particle size after an endurance triathlon.
Lamon-Fava S; McNamara JR; Farber HW; Hill NS; Schaefer EJ
Metabolism; 1989 Sep; 38(9):921-5. PubMed ID: 2505019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
